ARN-509: a novel antiandrogen for prostate cancer treatment.
Cancer Res. 2012 Mar 15;72(6):1494-503. doi: 10.1158/0008-5472.CAN-11-3948. Epub 2012 Jan 20.
Cancer Res. 2012.
PMID: 22266222
Free PMC article.